The pharmaceutical sector has been making headlines for large-scale layoffs, department closures and clinical trial failures.

With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, there could be a wealth of talent available to biopharma companies. Does ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...

The drug industry offered its first significant sign of pushback against the Trump administration late Tuesday, after a day of dramatic cuts to U.S. public health infrastructure. Drug stocks tumbled ...

The pharmaceutical industry experienced a period of rapid growth ... resulting in bankruptcies, job losses, and depressed valuations. Now, it appears that the malaise is creeping to almost all ...